Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Moderna Targets 2021 Back-To-School Season For Pediatric Data On COVID-19 Vaccine

Nov 03 2020

• By Derrick Gingery

Child with face mask getting vaccinated — The FDA said the expanded access pathway will not be used to make a vaccine available for children unless safety and immunogenicity data in that group is available. • Source: Shutterstock

Related Content

Where The COVID Vaccine Trials Stand: A Snapshot Of The Leaders And Rest Of The Field

Oct 21 2020

COVID Vaccines: Is Expanded Access A Better Option Than Emergency Use Authorization?

Oct 28 2020

Adolescents In COVID-19 Vaccine Trials: As Pfizer Starts Dosing, US FDA Encouraging Other Sponsors

Oct 24 2020

Lack Of Details On J&J COVID Vaccine Trial Safety Pause Raises ACIP Concerns About Transparency

Nov 05 2020

COVID-19 Vaccination Should Not Be Contraindicated For Women Who Are Pregnant, Breastfeeding

Nov 03 2020

Coronavirus Update: Gilead's Veklury Gets Full FDA Approval, Roche Partners With Atea

Oct 23 2020

Coronavirus Update: AstraZeneca’s Vaccine Trials Cleared To Restart In the US, J&J Prepares To Restart Its Vaccine Study

Oct 26 2020

Pfizer COVID-19 Vaccine Trial Diversity Slips As Enrollment Rises, Unlike Moderna

Sep 18 2020

When It Comes To A COVID-19 Vaccine For Kids, It Will Be Awhile

Sep 29 2020

Vaccine Hesitancy May Drive Distribution Priorities For Early COVID-19 Supply

Sep 23 2020

Related Companies

Moderna, Inc.

Pfizer Inc.

BioNTech SE

Johnson & Johnson

Additional Topics

United States Coronavirus COVID-19 Vaccines Clinical Trials Regulation Pediatrics BioPharmaceutical

More from Vaccines

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window